Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials

Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial

(2014) Jonathan P. Piccini et al.   Journal of the American Heart Association

Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation

(2013) Lars Wallentin et al.   CIRCULATION

Novel oral anticoagulants in gastroenterology practice

(2013) Jay Desai et al.   GASTROINTESTINAL ENDOSCOPY

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies

(2013) Arne Lauer et al.   LANCET NEUROLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brain Regulation of Thrombosis and Hemostasis

(2013) Mark J. Fisher   STROKE

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes

(2013) Daniel M. Witt et al.   THROMBOSIS RESEARCH

Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

(2012) Brian Dale et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Anticoagulation With the Oral Direct Thrombin Inhibitor Dabigatran Does Not Enlarge Hematoma Volume in Experimental Intracerebral Hemorrhage

(2011) Arne Lauer et al.   CIRCULATION

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Kinetics of hematoma expansion in murine warfarin-associated intracerebral hemorrhage

(2010) Sergio Illanes et al.   BRAIN RESEARCH

Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study

(2010) M. M. F. Poels et al.   STROKE

Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans

(2009) C. Weinz et al.   DRUG METABOLISM AND DISPOSITION

Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage

(2009) S.-H. Lee et al.   NEUROLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between Cerebral Microbleeds on T2*-Weighted MR Images and Recurrent Hemorrhagic Stroke in Patients Treated with Warfarin following Ischemic Stroke

(2008) H. Ueno et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.  

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

(2008) N. Raghavan et al.   DRUG METABOLISM AND DISPOSITION

Experimental Model of Warfarin-Associated Intracerebral Hemorrhage

(2008) Christian Foerch et al.   STROKE